For instance, in August 2024, Eli Lilly and Company announced positive topline results from the SURMOUNT-1 trial, a three-year study evaluating the effectiveness and safety of tirzepatide (marketed as Zepbound and Mounjaro) administered once weekly for long-term weight management and delaying the progression to diabetes in adults with pre-diabetes and obesity or overweight
4.92 million) is lower than the CHAP estimate of how many people were living with clinical Alzheimer's dementia only (6.07 million)
Raufman JP, Singh L, Singh G, and Eng J
A Korean study in the Journal of Korean Medical Science found that people with diffuse hair loss had notably lower ferritin
For women using GLP-1 medications, these lifestyle factors can pose additional challenges
Recently, several researchers created powders with nano-embedded microparticles (NEM)